Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Apricus resubmits Vitaros NDA

Aug. 30, 2017

Anthera reports topline data from BRIGHT-SC extension of blisibimod in IgA nephropathy

Aug. 30, 2017

Roche discloses new DDR1 inhibitors

Aug. 28, 2017

Lilly discovers novel phosphodiesterase PDE1 inhibitors

Aug. 25, 2017

TFAM overexpression rescues sperm defects in infertile mtDNA mutator mice

Aug. 22, 2017

Avadel and Serenity enter into exclusive negotiations for Noctiva

Aug. 18, 2017

Taiho Pharmaceutical begins enrolling patients in phase II study of TAC-302

Aug. 11, 2017

FDA grants orphan drug designation for blisibimod as treatment of IgA nephropathy

Aug. 10, 2017

Clearance for first-in-human study of ORBCEL-M for diabetic kidney disease

Aug. 7, 2017

FDA grants orphan drug designation to OMS-721 for IgA nephropathy

Aug. 7, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...